Fukuda Denshi Co., Ltd.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Fukuda Denshi Co., Ltd.'s yearly results (2023–2026), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Debt due within a year is covered 16.3 times by its yearly operating cash. Higher than 91% of Healthcare companies in Japan.
Where ¥100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
¥154Over the last 3 years, every ¥100 of reported profit came with ¥154 of operating cash.
Higher than 69% of Healthcare companies in Japan.
Self-Funding Ratio
1.8×Over the last 3 years its own operating cash covered its investment spending (capex) 1.8 times.
Higher than 60% of Healthcare companies in Japan.
Cash Locked Ratio
¥23For every ¥100 of sales, ¥23 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥27 tied up three years earlier.
More money tied up than 59% of Healthcare companies in Japan.
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Less steady than 55% of Healthcare companies in Japan.
Growth Efficiency Ratio
—Sales barely changed
Sales changed by +4% in 3 years, too little to measure extra profit per extra sales.
Asset Productivity Ratio
+4% / +9%In 3 years sales changed by +4% while total assets changed by +9%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
16.3×Debt due within a year is covered 16.3 times by its yearly operating cash.
Higher than 91% of Healthcare companies in Japan.
Cash Cushion Ratio
+21%Cash, after subtracting all debt, equals 21% of its market value (net cash).
Higher than 77% of Healthcare companies in Japan.
Tangible Assets Ratio
99%Of every ¥100 the company owns, ¥99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 74% of Healthcare companies in Japan.
Tangible Net Worth Ratio
99%Of every ¥100 of net worth, ¥99 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 75% of Healthcare companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Fukuda Denshi Co., Ltd. owes ¥0.16 for every ¥1 it owns. Net profit rose 1% in the year to Mar 2026, and grew 3% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
16.2Investors pay ¥16.2 for every ¥1 of Fukuda Denshi Co., Ltd.'s yearly profit, higher than 50% of Healthcare companies in Japan.
P/B ratio
1.57The share price is 1.57 times Fukuda Denshi Co., Ltd.'s book value per share, higher than 50% of Healthcare companies in Japan.
Market cap
¥302.0 BThe total market value of all of Fukuda Denshi Co., Ltd.'s shares at today's price (share price × number of shares), larger than 88% of Healthcare companies in Japan. PosiCap size class: Meso Cap.
Net worth (book value)
¥191.8 BWhat Fukuda Denshi Co., Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥7,101Net worth divided by the number of shares. The share price of ¥11,180 is 1.6 times this, which is the P/B above.
Return on equity (ROE)
10.5%Fukuda Denshi Co., Ltd. earned 10.5% on its shareholders' money over the last year, higher than 66% of Healthcare companies in Japan.
Owes vs Owns
0.16×Fukuda Denshi Co., Ltd. owes ¥0.16 for every ¥1 it owns (low), lower than 83% of Healthcare companies in Japan.
Dividend yield
1.46%Fukuda Denshi Co., Ltd. pays 1.46% of its share price as dividends a year, lower than 83% of dividend-paying Healthcare companies in Japan.
Revenue growth
+0%Revenue rose 0% in the year to Mar 2026, and grew 1% a year on average over 3 years.
Profit growth
+1%Net profit rose 1% in the year to Mar 2026, and grew 3% a year on average over 3 years.
Profit margin
13.5%Fukuda Denshi Co., Ltd. keeps ¥13 of every ¥100 of revenue as net profit.
Cash quality
1.6×Cash from Fukuda Denshi Co., Ltd.'s business was 1.6× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
466.8×Fukuda Denshi Co., Ltd.'s operating profit covered its interest costs 466.8 times in the year to Mar 2026.
Cash vs debt
Net cashFukuda Denshi Co., Ltd. held ¥62.2 B more cash than debt (net cash) at Mar 2026.
Questions
What is Fukuda Denshi Co., Ltd.'s P/E ratio?
Investors pay ¥16.2 for every ¥1 of Fukuda Denshi Co., Ltd.'s yearly profit, higher than 50% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Fukuda Denshi Co., Ltd.: ¥302.0 B ÷ ¥191.8 B (30 Jun 2026) = 1.6.
What is Fukuda Denshi Co., Ltd.'s return on equity?
Fukuda Denshi Co., Ltd. earned 10.5% on its shareholders' money over the last year, higher than 66% of Healthcare companies in Japan.
How much does Fukuda Denshi Co., Ltd. owe compared with what it owns?
Fukuda Denshi Co., Ltd. owes ¥0.16 for every ¥1 it owns (low), lower than 83% of Healthcare companies in Japan.
Does Fukuda Denshi Co., Ltd. pay a dividend?
Yes. Fukuda Denshi Co., Ltd. pays 1.46% of its share price as dividends a year, lower than 83% of dividend-paying Healthcare companies in Japan.
Is Fukuda Denshi Co., Ltd.'s revenue growing?
Revenue rose 0% in the year to Mar 2026, and grew 1% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.